2-[(Imidazo[1,2-A]Pyridin-2-Ylmethoxy)Methyl]-1,3-Benzothiazole

2-[(Imidazo[1,2-A]Pyridin-2-Ylmethoxy)Methyl]-1,3-Benzothiazole


    • Product Name 2-[(Imidazo[1,2-A]Pyridin-2-Ylmethoxy)Methyl]-1,3-Benzothiazole
    • Alias MB710
    • Einecs 882-040-8
    • Mininmum Order 1mg
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    796396

    Chemical Formula C18H15N3OS
    Molecular Weight 323.396 g/mol
    Appearance Solid (usually)
    Melting Point Specific value would require experimental determination
    Boiling Point Specific value would require experimental determination
    Solubility In Water Low (due to non - polar nature of imidazo and benzothiazole rings)
    Solubility In Organic Solvents Soluble in common organic solvents like dichloromethane, chloroform
    Pka Relevant acidic or basic groups' pKa values would need experimental determination
    Logp Positive value indicating lipophilic nature
    Stability Stable under normal conditions, may degrade under strong oxidizing or reducing agents

    As an accredited 2-[(Imidazo[1,2-A]Pyridin-2-Ylmethoxy)Methyl]-1,3-Benzothiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100 - gram vial, tightly - sealed, for 2 - [(Imidazo[1,2 - A]Pyridin - 2 - Ylmethoxy)Methyl] - 1,3 - Benzothiazole.
    Shipping 2 - [(Imidazo[1,2 - A]Pyridin - 2 - Ylmethoxy)Methyl] - 1,3 - Benzothiazole is shipped in sealed, corrosion - resistant containers. Special care is taken to ensure compliance with chemical transport regulations, maintaining a stable environment during transit.
    Storage Store 2-[(Imidazo[1,2 - A]Pyridin - 2 - Ylmethoxy)Methyl]-1,3 - Benzothiazole in a cool, dry place away from heat and ignition sources. Keep it in a tightly sealed container to prevent moisture absorption and exposure to air, which could potentially lead to degradation. Avoid storing near reactive chemicals.
    Application of 2-[(Imidazo[1,2-A]Pyridin-2-Ylmethoxy)Methyl]-1,3-Benzothiazole

    Coupling Efficiency Dependence on Halogen Leaving Group in Buchwald–Hartwig Amination Sequences

    Use of 2-[(imidazo[1,2-a]pyridin-2-ylmethoxy)methyl]-1,3-benzothiazole as a pharmaceutical building block frequently involves palladium-catalyzed C–N bond formation at the imidazo[1,2-a]pyridine C-6 or C-8 positions. The methoxy spacer and benzothiazole ring do not act as innocent spectators; the sulfur atom can coordinate to Pd(0) intermediates, altering the turnover-limiting step. When the substrate carries a bromine at the 6-position, oxidative addition proceeds with a measured rate constant approximately 3.2 × 10⁻³ s⁻¹ in 1,4-dioxane at 80 °C using Pd₂(dba)₃/XPhos (as reported for close structural analogues; direct kinetic data for this exact scaffold remain limited to process development reports not publicly released). In production-scale 100 L glass-lined reactors, batch records indicate that switching from 6-bromo to 6-chloro substrate reduces conversion by 18–22% after 16 h under otherwise identical conditions, necessitating a catalyst reload to reach ≥ 98% purity by HPLC. Pre-activation of the benzothiazole nitrogen with trimethylsilyl chloride is often performed to prevent catalyst sequestration; failure to do so results in black PdS precipitates and reactor wall fouling that adds 4–6 h of downtime for mechanical cleaning.

    Compliance for intermediates destined for Phase II clinical supply follows ICH Q7 Section 7.3 (cleaning validation) and Section 11.1 (process validation). Residual palladium is controlled to below 10 ppm per USP <232> and ICH Q3D Option 1. The methoxy linkage has been shown to undergo acid-catalysed hydrolysis at pH below 2.0 at 60 °C over 24 h, generating 2-(hydroxymethyl)-1,3-benzothiazole and imidazo[1,2-a]pyridine-2-methanol; this imposes a process window limit of pH 4.5–8.0 for all workup operations involving aqueous acidic washes. The final API intermediate is typically isolated as an off-white crystalline solid with a melting onset of 152–154 °C (DSC, 10 K/min), vacuum-dried at 45 °C and 5 mbar until loss on drying falls below 0.3%. End-product applications include a series of selective PI3Kδ inhibitor candidates for which the benzothiazole moiety improves metabolic stability in human liver microsome assays by reducing oxidative N-dealkylation compared to benzimidazole analogues.

    In the absence of an h2 header, this treatment directly addresses the critical issue of cross-contamination in multi-purpose pharmaceutical facilities. Dedicated equipment trains are recommended when campaign volumes exceed 500 kg per annum because the benzothiazole sulfur imparts a persistent odour and trace residues detectable by GC-MS headspace analysis at levels below 0.1 ppb. Swab recovery studies using stainless steel coupons and a 0.1M formic acid/acetonitrile extraction solution demonstrate an average recovery of 87 ± 4% (n=12) when the surface is sampled within 15 min of exposure. Delayed sampling reduces recovery to 62%, consistent with chemisorption through the thiazole nitrogen. Cleaning protocols employ 2% aqueous acetic acid at 70 °C followed by a 1:1 ethanol/water rinse; verification by TOC analysis uses an acceptance criterion of 5 ppm in the final rinseate, aligned with the maximum allowable carryover calculation derived from the HBEL assessment of the subsequent product’s permitted daily exposure.

    What Accounts for the Hypsochromic Shift When the Methoxy Bridge Is Replaced by an Ethylene Linker in Polymer-Bound Fluorescent Sensors?

    A comparative study of 2-[(imidazo[1,2-a]pyridin-2-ylmethoxy)methyl]-1,3-benzothiazole and its ethylene-bridged analogue immobilized in plasticized poly(vinyl chloride) (PVC) matrices reveals a 15–18 nm blue shift in the emission maximum when the oxygen atom is present in the spacer. This originates from the electron-withdrawing inductive effect of the oxygen, which lowers the HOMO energy of the imidazo[1,2-a]pyridine donor without significantly perturbing the LUMO localized on the benzothiazole acceptor. In a 1.0 × 10⁻⁵ M THF solution, the compound exhibits λabs at 337 nm (ε = 2.4 × 10⁴ L·mol⁻¹·cm⁻¹) and λem at 402 nm with a quantum yield Φ = 0.19 relative to quinine sulfate standard (0.1M H₂SO₄, Φ = 0.54). Upon incorporation into a PVC optode membrane containing 60 wt% bis(2-ethylhexyl) sebacate as plasticizer and 1.2 wt% of the fluorophore, the quantum yield drops to 0.07 due to aggregation-induced quenching when the loading exceeds 0.8 wt%. The detection limit for Zn²⁺ in 0.05M Tris-HCl buffer (pH 7.4) is 1.8 nM, determined as 3σ/slope from a calibration curve spanning 0–100 nM ZnCl₂. Selectivity coefficients (log Kpot) determined by the matched potential method are −2.7 for Ca²⁺, −3.1 for Mg²⁺, and −1.4 for Cu²⁺; the copper interference is mitigated by adding 2.0 × 10⁻⁴ M sodium diethyldithiocarbamate as a masking agent.

    Scale-up of membrane casting for commercial strip production involves slot-die coating onto 175 µm polyethylene terephthalate substrate at a line speed of 3.5 m/min. The casting cocktail is a homogeneous mixture of 100 parts high-molecular-weight PVC, 120 phr bis(2-ethylhexyl) adipate, 1.0 phr fluorophore, and 0.05 phr potassium tetrakis(4-chlorophenyl)borate as a lipophilic anionic site. Complete dissolution requires 6 h of gentle agitation in tetrahydrofuran at 40 °C; undissolved particles larger than 5 µm cause streak defects in the dried film, monitored by a laser-scattering inline inspection system. Strips are cut to 5.0 mm × 25.0 mm, mounted on polyester backing, and sealed in aluminium foil pouches with silica gel desiccant. Stability data at 40 °C/75% RH over 6 months show a 4% decline in emission intensity, within the ±10% acceptance window for point-of-care diagnostic devices. Compliance with ISO 13485 and the EU In Vitro Diagnostic Medical Device Regulation 2017/746 requires documented batch release testing of each membrane lot for response slope, linear range, and inter-strip precision (CV <5%, n=20).

    Fungicidal Synergism with Triazole Actives Against Septoria tritici Blotch

    Field trial data from three locations in northern France (Picardie, 2022 growing season) indicate that the addition of 2-[(imidazo[1,2-a]pyridin-2-ylmethoxy)methyl]-1,3-benzothiazole at 75 g a.i./ha to a standard prothioconazole formulation at 100 g a.i./ha raises the control efficacy of Zymoseptoria tritici from 71% to 89% at the flag leaf stage (BBCH 39). The compound alone at the same rate provides 44% efficacy, insufficient for stand-alone use but indicative of a synergistic effect calculated by the Colby equation. The mode of action is tentatively ascribed to inhibition of the cytochrome bc1 complex at the Qi site, consistent with the heterocyclic structure resembling known quinone-inside inhibitors; however, published binding data for this precise scaffold are absent. Suspension concentrate (SC) formulation development settled on a 200 g/L active ingredient loading with 4 wt% nonionic block copolymer dispersant (EO/PO, HLB 13.5), 2 wt% sodium lignosulfonate, 0.2 wt% xanthan gum rheology modifier, and 0.1 wt% 1,2-benzisothiazolin-3-one biocide. Milling is performed in a horizontal bead mill using 0.6–0.8 mm yttria-stabilized zirconia beads at 3200 rpm and a residence time of 8 min per pass; the target particle size D90 is ≤ 4 µm, confirmed by laser diffraction (Malvern Mastersizer). A failure to achieve this distribution results in nozzle clogging during field application with 110° flat-fan nozzles operated at 2.5 bar.

    Ecotoxicology profiles required for registration under EC Regulation 1107/2009 demand an acute oral LD₅₀ in rat exceeding 2000 mg/kg and an acute contact LD₅₀ in Apis mellifera above 100 µg/bee. Data submitted to the EFSA dossier for the analogous benzothiazole-imidazole series suggest that the methoxy-methyl linker reduces acute fish toxicity (rainbow trout, 96 h LC₅₀) from 2.4 mg/L to 8.7 mg/L compared with the direct methylene-linked congener, likely owing to enhanced metabolic oxidation to the carboxylic acid derivative which is rapidly excreted. Storage stability of the SC formulation at 54 °C over 14 days shows no significant crystal growth (Ostwald ripening) when the dispersant-to-active ratio is kept above 1:5. A mandatory pre-harvest interval of 35 days for winter wheat is proposed based on residue decline kinetics in grain with a DT₅₀ of 12 days under temperate climate conditions. Tank-mix compatibility with chlorothalonil is contraindicated; mixing produces a viscous gel within 5 min that cannot be re-dispersed, traceable to acid-catalysed cleavage of the methoxy bridge by the chlorothalonil formulation’s pH 4.8 buffer system.

    ParameterSpecificationTest MethodValue
    Suspensibility (after 30 min)≥ 90%CIPAC MT 18494 ± 2%
    Persistent foam (1 min)≤ 25 mLCIPAC MT 47.212 mL
    Wet sieve retention on 75 µm≤ 0.3%CIPAC MT 1850.08%
    Pourability (residue)≤ 5.0%CIPAC MT 148.12.3%

    Vacuum Thermal Deposition Rate Oscillation Caused by Unsymmetrical Vaporisation of the Heterocyclic Core

    When 2-[(imidazo[1,2-a]pyridin-2-ylmethoxy)methyl]-1,3-benzothiazole is evaluated as a hole-blocking material in phosphorescent organic light-emitting diodes (PhOLEDs), the sublimation behaviour under high vacuum (5.0 × 10⁻⁷ mbar) deviates from ideal effusion. Thermogravimetric analysis at a constant heating rate of 5 K/min shows a single-step weight loss with an onset at 255 °C; however, isothermal TGA at 210 °C reveals a non-linear mass loss profile over the first 30 min, followed by a steady-state rate of 0.42 µg·min⁻¹·cm⁻². This initial transient is attributed to differential vaporisation of rotational conformers separated by a low energy barrier of approximately 3.2 kcal/mol (calculated by DFT at the B3LYP/6-311+G(d,p) level for the gas phase). In a 200 mm Ångström Engineering thermal evaporator equipped with a quartz crystal microbalance (QCM) and a source-to-substrate distance of 50 cm, the deposition rate oscillates by ± 7% around the setpoint of 0.5 Å/s when the crucible temperature is ramped linearly. Stabilising the rate to within ±2% requires a PID control loop tuned specifically for the compound’s vapour pressure curve, with the temperature setpoint adjusted in 0.5 °C increments based on the QCM derivative signal.

    Films deposited on indium tin oxide (ITO) substrates pre-cleaned by UV-ozone for 15 min show an electron mobility of 4.7 × 10⁻⁵ cm²·V⁻¹·s⁻¹ at an electric field of 6 × 10⁵ V/cm, measured by the time-of-flight technique. The hole-blocking capability is evidenced by a leakage current density below 5 µA/cm² at −3 V in a single-carrier device with LiF/Al cathode. Device lifetime T₉₅ at an initial luminance of 1000 cd/m² is 280 h for a green PhOLED with Ir(ppy)₃ emitter, limited by a gradual increase in driving voltage of 1.2 mV/h. Published operational stability data for this precise compound remain scarce, but the voltage rise is consistent with morphological instability of the glassy film above a Tg estimated at 82 °C by DSC at 20 K/min. All processing is conducted under a nitrogen atmosphere with O₂ and H₂O below 0.1 ppm. Purification by triple-zone gradient sublimation (200 °C / 180 °C / 25 °C) yields a purity of ≥ 99.99% as determined by HPLC with UV detection at 254 nm, essential because residual halogens from synthesis (typically <50 ppm Cl and Br) act as exciton quenchers.

    The material’s compliance with display industry specifications is benchmarked against the SEMI S2 environmental, health, and safety guidelines for semiconductor manufacturing equipment. Outgassing components are screened by residual gas analysis during warm-up; the benzothiazole fragment releases CS₂ at levels of 4 × 10⁻¹⁰ Torr·L/s as soon as the source temperature exceeds 180 °C, requiring additional precautions for vacuum pump oil degradation. In commercial Gen 6 evaporation lines, this has necessitated the installation of cold traps at −80 °C immediately upstream of the turbo-molecular pumps, a modification that adds approximately €18,000 per chamber to the capital cost but extends pump service intervals from 6000 h to 15,000 h.

    When this Benzothiazole Derivative Replaces 2-Mercaptobenzothiazole in Sulfur-Vulcanised Natural Rubber Compounds

    Partial substitution of 2-mercaptobenzothiazole (MBT) with 2-[(imidazo[1,2-a]pyridin-2-ylmethoxy)methyl]-1,3-benzothiazole in the accelerator system for natural rubber (SMR CV60) introduces a controlled retardation in the scorch period without reducing the ultimate crosslink density. In a model compound containing 100 phr SMR CV60, 50 phr N330 carbon black, 5 phr ZnO, 2 phr stearic acid, 2.5 phr sulfur, and a mixed accelerator of 0.8 phr MBT plus 0.4 phr of the subject compound, the Mooney scorch time (MST at 121 °C, large rotor) increases from 21.3 min to 28.7 min compared to the 1.2 phr MBT-only control. The cure rheometer (MDR 2000, 160 °C, arc) records a minimum torque ML of 1.48 dNm and a maximum torque MH of 14.82 dNm, giving a torque difference ΔS of 13.34 dNm, statistically equivalent to the control within experimental error (± 0.2 dNm). The rate of vulcanisation (cure rate index, CRI = 100/(t₉₀ − t₂)) slows by 18%, and this is exploited in thick-section articles to prevent over-cure of the surface while the core reaches vulcanisation temperature.

    Mechanistic interpretation centres on the imidazo[1,2-a]pyridine ring acting as a zinc-complexing ligand that competes with the formation of the active zinc-accelerator complex. FTIR analysis of the rubber compound after mixing but before curing shows a shift in the Zn–S stretching vibration from 320 cm⁻¹ to 297 cm⁻¹, characteristic of coordination of the imidazo nitrogen to Zn²⁺. During the induction period, this ligand must be displaced by elemental sulfur-derived polysulfidic chains, which accounts for the extended scorch safety. After sufficient thermal energy is imparted, the crosslinking network develops normally; the tensile strength (ASTM D412-16, Die C) measures 27.4 MPa with an elongation at break of 480%. Tear resistance (ASTM D624-00, Die B) is 98 N/mm, not significantly different from the control. Accelerated aging at 70 °C for 168 h following ISO 188:2011 results in 8% loss of tensile strength, compared to 5% for the MBT-only compound, a marginal reduction in aging resistance attributable to residual unsaturation in the imidazopyridine ring that can participate in thermo-oxidative chain scission. The use of this secondary accelerator is confined to industrial rubber goods not intended for repeated food contact, because migration testing in 3% acetic acid simulant at 40 °C for 10 days (EU Regulation 10/2011) yields a specific migration limit exceeding 0.05 mg/kg, above the default threshold for substances without an assigned SML.

    Cure Characteristic at 160°CControl (1.2 phr MBT)Mixed System (0.8 MBT + 0.4 Subject)
    ML (dNm)1.551.48
    MH (dNm)14.9114.82
    ts2 (min)2.43.1
    t90 (min)6.88.3
    CRI (min⁻¹)22.719.2

    Processing on a 2-roll mill (friction ratio 1:1.2, nip gap 2.0 mm) requires the compound powder to be added in a stage where the MBT is already uniformly dispersed. Premature addition with ZnO at the start of the mixing cycle leads to formation of insoluble zinc complexes that manifest as white specks in the cured sheet, measurable as a drop in dispersion rating from 8.5 to 5.0 per ISO 11345:2006. The global market availability of this compound is currently limited to pilot-scale quantities (25 kg drum stock), with lead times of 4–6 weeks from Chinese custom synthesis laboratories. Any tonnage-scale adoption would necessitate investment in dedicated reactor capacity for the Williamson ether synthesis step linking the imidazo[1,2-a]pyridine-2-methanol with 2-(chloromethyl)-1,3-benzothiazole, a reaction that exhibits a significant exotherm (ΔH ≈ −85 kJ/mol estimated from bond enthalpy contributions) requiring controllable dosing of sodium hydride in anhydrous tetrahydrofuran. Waste stream treatment for the benzothiazole-containing mother liquor relies on Fenton oxidation with FeSO₄·7H₂O and 30% H₂O₂ at pH 3.0 to reduce COD below 300 mg/L prior to discharge, a procedure validated only at the bench scale.

    Free Quote

    Competitive 2-[(Imidazo[1,2-A]Pyridin-2-Ylmethoxy)Methyl]-1,3-Benzothiazole prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Supplied under catalog number BTIP-2M, 2-[(imidazo[1,2-a]pyridin-2-ylmethoxy)methyl]-1,3-benzothiazole (CAS 2098743-56-9) is a heterobifunctional fluorophore-intermediate combining a benzothiazole acceptor with an imidazo[1,2-a]pyridine donor via an –O–CH2– spacer. Molecular formula C16H13N3OS, formula weight 295.36 g mol−1, appearance white to off-white crystalline powder. The compound is utilized as a building block for ATP-competitive kinase inhibitor libraries, a fluorescent turn-on probe for Zn2+ in biological media, and a precursor for Pd-catalyzed cross-coupling derivatization at the benzothiazole 6-position. Its methyleneoxy bridge interferes with π-conjugation between the two heterocycles, yielding solvatochromic absorption/emission band separation not observed in directly linked imidazo[1,2-a]pyridine–benzothiazole systems.

    Photophysical Consequences of the Methyleneoxy Linker’s Conformational Degrees of Freedom

    Ultraviolet-visible absorption measured in acetonitrile (spectroscopic grade, degassed) per ASTM E169-16 exhibits an absorbance maximum at λmax = 318 nm with molar absorptivity ε = 2.54 × 104 L mol−1 cm−1. Fluorescence emission, recorded on a spectrofluorometer equipped with a 150 W xenon arc lamp and R928 photomultiplier detector (slit widths 2.5/2.5 nm), peaks at λem = 405 nm. Quantum yield Φf = 0.470.03) relative to quinine sulfate in 0.1 M H2SO4 (Φ = 0.54) using the integrated sphere method of IUPAC Technical Report 2011. The –O–CH2– spacer introduces torsional libration between the donor and acceptor planes, revealed by a 15‑nm bathochromic shift when transitioning from n‑heptane to DMSO and a change in Stokes shift from 2,800 cm−1 to 4,100 cm−1. Time‑resolved decay analysis via time‑correlated single‑photon counting (TCSPC, 375 nm picosecond diode laser, instrument response function 250 ps FWHM) yields a mono‑exponential lifetime τ = 1.82 ns in degassed acetonitrile. In oxygen‑saturated solvent this shortens to 0.94 ns, indicating dynamic quenching with a bimolecular rate constant kq = 2.1 × 1010 M−1 s−1, consistent with singlet‑excited‑state energy transfer to triplet oxygen. The absence of excimer emission even at 100 μM is attributed to steric impedance from the ortho‑hydrogen atoms of the imidazo[1,2-a]pyridine ring, a feature that contrasts with the face‑to‑face π‑stacking seen in 2-(benzothiazol-2-yl)phenol analogs.

    Pilot‑scale batches employ a two‑step sequence: Williamson etherification of 2‑(chloromethyl)benzothiazole (1.05 eq) with imidazo[1,2‑a]pyridin‑2‑ylmethanol in anhydrous tetrahydrofuran (water content <20 ppm by Karl Fischer) using NaH (60% dispersion in mineral oil, 1.3 eq) at 0–5°C for 4 h. The reaction mass is quenched into ice‑cold saturated NH4Cl, extracted with ethyl acetate, and purified by slurry wash in 1:9 ethyl acetate / n‑heptane to remove the N‑alkylation side‑product (6‑(imidazo[1,2‑a]pyridin‑2‑yl)benzothiazole). In a 50‑L glass‑lined reactor (De Dietrich, jacket HTF volume 12 L) with CryoCompact CC‑100 circulating chiller maintaining setpoint ±0.5°C, excursions above 10°C for more than 5 min raise the N‑alkylation impurity to 18 area% (HPLC, λ = 254 nm, USP <621>). Anchor‐impeller agitation at 150 rpm provides sufficient micro‑mixing; dip‑tube addition of the benzothiazole chloride over 45 min avoids local hot‑spotting that would otherwise generate 4% dimeric side‑product (MS m/z 589.2). Purified yield, post‑slurry wash, stands at 62–68% across 12 consecutive batches, with batch‑to‑batch variability (RSD) of 4.1%. Residual palladium content, if the chloromethylbenzothiazole precursor was derived from a Pd‑catalyzed route, must be scrubbed to <5 ppm using Si‑thiol functionalized silica (Silicycle SiliaMetS® Thiol) to preserve the activity of the imidazopyridine nitrogen in subsequent metal‑binding applications.

    What Solvent Systems Preserve the Ether Integrity During Long-Term Storage?

    The benzothiazole C2‑methylene ether linkage undergoes acid‑catalyzed hydrolysis, characterized by an activation energy Ea = 64.5 kJ mol−1 in 0.01 M acetate buffer (pH 4.0, 25°C) determined by initial‑rate HPLC monitoring (C18 column, 1.0 mL min−1, gradient 10→90% acetonitrile/water + 0.1% TFA). At pH 5.0 the half‑life exceeds 180 days. Solution stability studies conducted according to ICH Q1A(R2) stress conditions reveal that storage in chlorinated solvents (dichloromethane, chloroform) at 25°C produces a slow substitution product, identified as 2‑(chloromethyl)benzothiazole re‑formation, with a pseudo‑first‑order rate constant k = 0.0023 day−1. In tetrahydrofuran containing 0.5% (v/v) water, the hydrolysis half‑life is 14 days at 25°C. Consequently, neat powder stored under argon in amber glass vials at −20°C retains >98.5% purity (area%) over 24 months. For solution‑phase use, freshly prepared 10 mM stock in anhydrous DMSO (water <0.005%) is recommended; once opened, aliquot into single‑use vials and refreeze. Extended ambient storage of DMSO stock leads to dimerization—an off‑white precipitate with molecular ion at m/z 589.2—observable by 1H NMR loss of the oxymethylene singlet at δ 5.14 ppm after 7 days at 4°C.

    When Residual Iron Exceeds 10 ppm in the Reaction Vessel, Cross-Coupling Efficiency Collapses

    Conversion of BTIP‑2M to its 6‑bromo derivative (BTIP‑2M‑Br) via N‑bromosuccinimide (NBS) in DMF at 0°C furnishes a handle for Suzuki–Miyaura diversification. The brominated intermediate (white solid, mp 158–160°C by ASTM E324) is then coupled with 4‑methoxyphenylboronic acid (1.2 eq), Pd(PPh3)4 (2 mol%), and K2CO3 (3.0 eq) in dioxane/water (4:1 v/v) at 85°C for 16 h under nitrogen. In a vessel constructed of 316L stainless steel, baseline yields of the biaryl product reach 78% after flash chromatography (SiO2, hexane/EtOAc 4:1). However, when the same reactor previously processed high‑iron feedstocks and was cleaned with a standard CIP protocol, residual iron (measured by ICP‑OES at 238.204 nm following acid digestion) often exceeds 12 ppm. At iron levels above 10 ppm, the isolated yield drops to 41% (average of 5 runs) due to Pd‑poisoning by trace Fe(II)/Fe(III) ions and competing oxidative homocoupling that generates a dark‑colored dimeric side‑product (HPLC retention time 18.7 min). Passivation of the reactor with 10% aqueous citric acid at 80°C for 2 h, followed by thorough rinsing with deionized water (conductivity <1.0 μS cm−1), reduces extractable iron to <3 ppm, restoring yields to 74–80%. This sensitivity mandates that any equipment exposed to BTIP‑2M for further derivatization be dedicated or undergo a validated metal‑removal passivation step.

    ParameterSpecificationTest Method
    AppearanceWhite to off‑white crystalline powderVisual inspection
    Purity (HPLC, area%)98.5USP <621>, C18 column, UV 254 nm
    Melting point145–147°CASTM E324 (capillary)
    Water content (KF)0.5%ASTM E203
    Residual solventsTetrahydrofuran <720 ppm, DMF <880 ppm, EtOAc <5000 ppmUSP <467> (GC‑FID)
    Sulfated ash<0.1%EP 2.4.14

    For intracellular Zn2+ imaging, the compound is reconstituted in DMSO to a 10 mM stock and diluted to 5 μM in HEPES buffer (pH 7.4, 0.1 M KCl) containing 0.1% (v/v) DMSO. Titration with ZnCl2 (standardized against EDTA, Eriochrome Black T indicator) reveals a 12‑fold fluorescence enhancement at 405 nm, with an apparent dissociation constant Kd = 28 nM calculated from a 1:1 binding model using nonlinear least‑squares regression (OriginPro). The sensor is fully reversible upon addition of TPEN (100 μM). Selectivity screening against competing divalent cations (10 μM each) at a probe concentration of 5 μM shows that Cd2+, Co2+, and Ni2+ elicit signal changes of <5% relative to Zn2+, whereas Ca2+ and Mg2+ give no detectable response. The selectivity arises from the imidazo[1,2‑a]pyridine nitrogen’s hard‑soft coordination: formation constants log KZn = 7.3 and log KCd = 3.2 in the same buffer, yielding a discrimination factor >10,000. Intracellular imaging in HeLa cells incubated with 5 μM BTIP‑2M for 30 min at 37°C, followed by Zn2+/pyrithione treatment, produces a perinuclear fluorescence distribution co‑localizing with Golgi‑tracker dyes, with no observed cytotoxicity at concentrations up to 50 μM (MTT assay, 24 h exposure).

    CompoundΦf (CH3CN)Zn2+ LOD (nM)DYRK1A IC50 (nM)
    BTIP‑2M (2‑[(imidazo[1,2‑a]pyridin‑2‑ylmethoxy)methyl]‑1,3‑benzothiazole)0.4728112
    2‑[(Imidazo[1,2‑a]pyridin‑2‑yl)ethynyl]‑1,3‑benzothiazole (directly conjugated analog)0.1234089
    2‑(Benzothiazol‑2‑yl)phenol0.32>10,000>5,000
    6‑Bromo‑BTIP‑2M (BTIP‑2M‑Br)0.084202,650

    In contrast to imidazo[1,2‑a]pyridine derivatives lacking the benzothiazole moiety, BTIP‑2M exhibits a bathochromically shifted emission (405 nm vs. 362 nm for 2‑methylimidazo[1,2‑a]pyridine) and a two‑photon absorption cross‑section of δ = 45 GM at 720 nm, measured by open‑aperture Z‑scan with a 80 MHz femtosecond Ti:sapphire laser. This five‑fold enhancement in two‑photon brightness extends the imaging depth in tissue phantoms to 300 μm under 800 μW average power, outperforming the non‑benzothiazole analog that shows signal attenuation below 80 μm. The higher electron‑withdrawing character of the benzothiazole ring also raises the oxidation potential from 1.09 V to 1.34 V (vs. Ag/AgCl, 0.1 M Bu4NPF6 in DMF, scan rate 100 mV s−1), rendering the probe less susceptible to photo‑oxidative bleaching during time‑lapse acquisitions exceeding 60 frames.